Sign in

CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
271041563
Phone
949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 8-K Event Executive or director change · Shareholder vote results
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Executive or director change
  9. 4 Insider Changes in Ownership
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. SC 13D/A Stake Beneficial Ownership Report
  14. DEFA14A Proxy Proxy Materials
  15. EFFECT Other Notice of Effectiveness
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 25 of 35 · 688 filings